OpenVSafe by OpenVAERS
Search V-safe

A6T-31113-34246

2 vaccinations 4 coded responses 25 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
328 / FL
Registered
2021-04-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-12
    Registered in v-safe
  2. 2021-04-12
    Dose 1 — Moderna
  3. 2021-04-12
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  8. 2021-04-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · None
    Adult check-in
  9. 2021-04-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · None
    Adult check-in
  10. 2021-04-19
    Survey response — day 7, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Headache
    Free text: Lymph node swelling in underarm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-03
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-05-10
    Dose 2 — Moderna
  14. 2021-05-10
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-05-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-05-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-07
    Survey response — day 28, dose 2
    MedDRA: Headache, Insomnia, Menstruation irregular, Night sweats — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Irregular menstrual periodPersistent headacheNight sweatsSleeplessness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-06-14
    Survey response — day 35, dose 2
    MedDRA: Headache, Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Abnormally long menstrual period, a second menstrual period within 1 week of the first menstrual period, persistent headache over 5+ days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-06-21
    Survey response — day 42, dose 2
    MedDRA: Night sweats — Feeling: Good · Be unable to do your normal daily activities
    Free text: 3-week long moderate-to-heavy menstrual bleeding, with a very shortened overall menstrual cycle -- only one week in between bleeding. Continued night sweats and interrupted sleep.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-08-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-08
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-12Moderna
22021-05-10Moderna

Free text

Release 7 — day 7, dose 1

2021-04-19

Systemic reaction (other): Lymph node swelling in underarm

Release 8 — day 28, dose 2

2021-06-07

Symptoms: Irregular menstrual periodPersistent headacheNight sweatsSleeplessness

Release 9 — day 35, dose 2

2021-06-14

Symptoms: Abnormally long menstrual period, a second menstrual period within 1 week of the first menstrual period, persistent headache over 5+ days.

Release 9 — day 42, dose 2

2021-06-21

Symptoms: 3-week long moderate-to-heavy menstrual bleeding, with a very shortened overall menstrual cycle -- only one week in between bleeding. Continued night sweats and interrupted sleep.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache ✓ ✓ ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDInsomnia ✓ ✓ ✓
SDMenstruation irregular ✓ ✓ ✓
SDNight sweats ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release